Aliskiren: Preclinical evidence for the treatment of hyperproliferative skin disorders.
Pawloski PL, Moreira CG, Horinouchi CDS, Fernandes D, Olchanheski LR Júnior, Machado W, Cabrini DA, Dietrich M, Paludo K, Otuki MF.
Pawloski PL, et al. Among authors: cabrini da.
Biomed Pharmacother. 2018 Aug;104:151-157. doi: 10.1016/j.biopha.2018.03.157. Epub 2018 May 14.
Biomed Pharmacother. 2018.
PMID: 29772435